Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear

Sponsor
Kaohsiung Veterans General Hospital. (Other)
Overall Status
Recruiting
CT.gov ID
NCT04586361
Collaborator
(none)
150
1
3
23
6.5

Study Details

Study Description

Brief Summary

Purpose: The purpose of this article is to examine the clinical application of PRP and PRP+hyaluronic acid in disorders in the knee.

Methods:

The study was conducted on 150 adult patients with age over 20 years old affected by unilateral ACL complete tear and receiving ACL reconstruction. We divided the patients in three groups, and we treated the group A with perioperative injection of HHA, group B with perioperative HHA+PRP, group C with perioperative normal saline.

Follow-up:

Every 1,3,and 12months, we recheck physical exmianation at OPD and recheck MRI at postoperative 3 months.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: RegenLab PRP
  • Combination Product: hyaluronic acid
  • Other: normal saline
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear
Anticipated Study Start Date :
Oct 15, 2020
Anticipated Primary Completion Date :
Sep 15, 2021
Anticipated Study Completion Date :
Sep 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group 1

Intraoperative1 kit of Platelet-rich plasma(PRP) injection into knee joint after anterior cruciate ligament (ACL) reconstruction.

Combination Product: RegenLab PRP
PRP preparations also improved functional outcome scores compared to hyaluronic acid and placebo in patients affected by knee osteoarthritis (OA). Based on previous studys, we can conclude that the PRP treatment is a safe and efficacious procedure which can provide functional benefit.

Experimental: Experimental group 2

Intraoperative1 kit of PRP+Hyaluronic acid(HA) injection into knee joint after ACL reconstruction.

Combination Product: hyaluronic acid
Few studies investigated the effects of HA+PRP combined treatment for knee osteoarthritis (OA). Numerous studies demonstrated the efficacy of HA injection therapy in knee OA for a clinical point of view, reducing the pain and improving the quality of life.
Other Names:
  • RegenLab PRP
  • Placebo Comparator: Experimental group 3

    Intraoperative 20 ml normal saline injection into knee joint after ACL reconstruction.

    Other: normal saline
    In this study, we compare introperative PRP/PRP+HA/normal saline in ACL reconstruction patient.

    Outcome Measures

    Primary Outcome Measures

    1. 150 of participants with preoperative and postoperative physical examination are accessed by anterior drawer test and Lachman test [postoperative 1 month]

      the investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist

    2. 150 of participants with preoperative and postoperative physical examination are accessed by anterior drawer test and Lachman test [postoperative 3 months]

      the investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist

    3. 150 of participants with preoperative and postoperative physical examination are accessed by anterior drawer test and Lachman test [postoperative 12 months]

      the investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist

    4. 150 of participants with preoperative and postoperative Magnetic Resonance Imaging are accessed [postoperative 3 month]

      anterior cruciate ligament was accessed by MRI T1 and T2 image; MRI was checked by one orthopedist

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • receiving unilateral ACL reconstruction in our hospital

    • postoperative follow-up over 3 month

    Exclusion Criteria:
    • postoperative follow-up less than 3 month

    • possible pregnency

    • with coagulation disease

    • NSAIDs intake during study period

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kaohsiung Veterans General Hospital Kaohsiung 高雄市 Taiwan 813

    Sponsors and Collaborators

    • Kaohsiung Veterans General Hospital.

    Investigators

    • Principal Investigator: Yi Ping Wei, MD, Kaohsiung Veterans General Hospital.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yi Ping Wei, Chief resident, Orthopedics department, Kaohsiung Veterans General Hospital; Principal Investigator, Kaohsiung Veterans General Hospital.
    ClinicalTrials.gov Identifier:
    NCT04586361
    Other Study ID Numbers:
    • 200527-2
    First Posted:
    Oct 14, 2020
    Last Update Posted:
    Oct 14, 2020
    Last Verified:
    Oct 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Yi Ping Wei, Chief resident, Orthopedics department, Kaohsiung Veterans General Hospital; Principal Investigator, Kaohsiung Veterans General Hospital.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 14, 2020